Educational Mock Type II Drug Master File (DMF) for Metformin Hydrochloride USP: A CTD Module 3 (Quality) Regulatory Dossier
Abstract
This repository contains an educational mock Type II Drug Master File (DMF) prepared for Metformin Hydrochloride USP in accordance with the Common Technical Document (CTD) Module 3 (Quality) format. This dossier was developed for academic, professional training, and portfolio purposes to demonstrate practical knowledge of Chemistry, Manufacturing, and Controls (CMC) documentation and regulatory submission practices. The document includes: Administrative information Drug Substance (CTD S.1) Manufacture (CTD S.2) Characterization (CTD S.3) Control of Drug Substance (CTD S.4) Reference Standards and Materials (CTD S.5) Container Closure System (CTD S.6) Stability (CTD S.7) Executive Summary Manufacturing Flow Diagram Process Validation Summary Analytical Method Validation Risk Assessment (ICH Q9) Stability Trend Analysis Supporting Appendices The dossier has been prepared with reference to publicly available regulatory guidance, including FDA Drug Master File guidance, ICH quality guidelines, and the United States Pharmacopeia (USP). Important Notice This document is an educational mock regulatory dossier. All company names, manufacturing facilities, batch records, personnel, validation data, analytical results, and regulatory identifiers are fictional unless explicitly cited from public regulatory references. This work is not an official regulatory submission, notis intended for commercial use, and must not be represented as a genuine Drug Master File submitted to any…
Read the paper
Related studies
- Metformin as an adjuvant in breast cancer treatment
- Metformin Lysosomal Targeting: A Novel Aspect to Be Investigated for Metformin Repurposing in Neurodegenerative Diseases?
- Aberrant HSF1 signaling activation underlies metformin amelioration of myocardial infarction in mice
- Metformin induces ZFP36 by mTORC1 inhibition in cervical cancer-derived cell lines
- Protein Interaction Network for Identifying Vascular Response of Metformin (Oral Antidiabetic)
- Preventing Long COVID With Metformin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.